Shandong Sinoglory Health (603182) — Cash Flow Reinvestment Rate
Shandong Sinoglory Health (603182) has a Cash Flow Reinvestment Rate of 0.69x as of December 2025, reinvesting CN¥54.79 Million (capex CN¥54.75 Million plus investments CN¥47.63K) from operating cash flow of CN¥79.36 Million. See Shandong Sinoglory Health (603182) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Sinoglory Health Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Shandong Sinoglory Health across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shandong Sinoglory Health.
Annual Cash Flow Reinvestment Rate for Shandong Sinoglory Health (2020–2025)
Year-by-year capital reinvestment analysis for Shandong Sinoglory Health. See financial agility of Shandong Sinoglory Health to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥54.79 Million | CN¥79.36 Million | CN¥54.75 Million | ▼ -45.9% |
| 2024 | 1.28x | CN¥400.44 Million | CN¥313.81 Million | CN¥399.54 Million | ▼ -84.4% |
| 2023 | 8.19x | CN¥305.65 Million | CN¥37.34 Million | CN¥154.79 Million | ▲ +650.5% |
| 2022 | 1.09x | CN¥119.07 Million | CN¥109.17 Million | CN¥45.29 Million | ▼ -26.1% |
| 2021 | 1.48x | CN¥63.94 Million | CN¥43.34 Million | CN¥33.70 Million | ▲ +15.1% |
| 2020 | 1.28x | CN¥140.67 Million | CN¥109.73 Million | CN¥71.10 Million | — |